Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness.

OBJECTIVE Hospital care for children with viral lower respiratory illness (VLRI) is highly variable, and its relationship to severity and impact on outcome is unclear. Using the Pediatric Comprehensive Severity Index, we analyzed the correlation of institutional practice variation with severity and resource utilization in 10 children's medical centers. METHODS Demographics, clinical information, laboratory results, interventions, and outcomes were extracted from the charts of consecutive infants with VLRI from 10 children's medical centers. Pediatric Component of the Comprehensive Severity Index scoring was performed at admission and at maximum during hospitalization. The correlation of patient variables, interventions, and resource utilization at the patient level was compared with their correlation at the aggregate institutional level. RESULTS Of 601 patients, 1 died, 6 were discharged to home health care, 4 were discharged to rehabilitative care, and 2 were discharged to chronic nursing care. Individual patient admission severity score correlated positively with patient hospital costs (r = 0.48), but institutional average patient severity was negatively correlated with average institutional costs (r = -0.26). Maximal severity score correlated well with costs (r = 0.66) and length of stay (LOS; r = 0.64) at the patient level but poorly at the institutional level (r = 0.07 costs; r = 0.40 LOS). The institutional intensity of therapy was negatively correlated with admission severity (r = -0.03) but strongly correlated with costs (r = 0.84) and LOS (r = 0.83). CONCLUSIONS Institutional differences in care practices for children with VLRI were not explained by differences in patient severity and did not affect the children's recovery but correlated significantly with hospital costs and LOS.

[1]  S. Horn,et al.  Severity assessment in children hospitalized with bronchiolitis using the pediatric component of the Comprehensive Severity Index , 2000, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[2]  F. Walther,et al.  Looking back in time: outcome of a national cohort of very preterm infants born in The Netherlands in 1983. , 2000, Early human development.

[3]  S. Horn,et al.  A comparison of the pediatric comprehensive severity index with the pediatric risk of mortality (PRISM III) score , 1999 .

[4]  S. Horn,et al.  ABILITY OF THE PEDIATRIC COMPREHENSIVE SEVERITY INDEX TO PREDICT LENGTH OF STAY AND COSTS , 1999 .

[5]  G. Marshall,et al.  Standardizing the care of bronchiolitis. , 1998, Archives of pediatrics & adolescent medicine.

[6]  P. Seddon,et al.  Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. , 1998, The Journal of pediatrics.

[7]  S. McMahon,et al.  The Use of Albuterol in Hospitalized Infants With Bronchiolitis , 1998, Pediatrics.

[8]  J. Dean,et al.  Albuterol in Acute Bronchiolitis—Continued Therapy Despite Poor Response? , 1998, Pharmacotherapy.

[9]  R. Horwitz,et al.  Efficacy of β2-Agonists in Bronchiolitis: A Reappraisal and Meta-analysis , 1997 .

[10]  E. Wang,et al.  Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. , 1997, The Journal of pediatrics.

[11]  T. Klassen,et al.  Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. , 1997, The Journal of pediatrics.

[12]  J. Kellner,et al.  Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. , 1996, Archives of pediatrics & adolescent medicine.

[13]  E. Wang,et al.  Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. , 1996, The Journal of pediatrics.

[14]  R. Tanz,et al.  Dexamethasone in bronchiolitis: a randomised controlled trial , 1996, The Lancet.

[15]  J. Hendley,et al.  Invasive monitoring in infants with respiratory syncytial virus infection. , 1996, The Journal of pediatrics.

[16]  M. Everard,et al.  Bronchiolitis , 1995, Drugs.

[17]  I. Strannegård,et al.  Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers. , 1993, Archives of disease in childhood.

[18]  M J Coye,et al.  A study of the relationship between severity of illness and hospital cost in New Jersey hospitals. , 1992, Health services research.

[19]  P. Schweich,et al.  The use of nebulized albuterol in wheezing infants. , 1992, Pediatric emergency care.

[20]  S. Horn,et al.  Severity of illness and resource use differences among white and black hospitalized elderly. , 1992, Archives of internal medicine.

[21]  R. Seifer,et al.  The efficacy of nebulized metaproterenol in wheezing infants and young children. , 1992, American journal of diseases of children.

[22]  E. Wang,et al.  Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. , 1992, Archives of disease in childhood.

[23]  P. L. Le Souef,et al.  Effect of salbutamol on oxygen saturation in bronchiolitis. , 1991, Archives of disease in childhood.

[24]  T. Klassen,et al.  Randomized trial of salbutamol in acute bronchiolitis. , 1991, The Journal of pediatrics.

[25]  R F Averill,et al.  The Relationship Between Severity of Illness and Hospital Length of Stay and Mortality , 1991, Medical care.

[26]  H. Levison,et al.  Nebulized albuterol in acute bronchiolitis. , 1990, The Journal of pediatrics.

[27]  S. Godfrey,et al.  Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis , 1990, Pediatric pulmonology.

[28]  C. Hall,et al.  Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. , 1988, The Journal of pediatrics.

[29]  R. Horn,et al.  Misclassification problems in diagnosis-related groups. Cystic fibrosis as an example. , 1986, The New England journal of medicine.

[30]  R. Horn,et al.  Reliability and Validity of the Severity of Illness Index , 1986, Medical care.

[31]  R. Horn,et al.  Severity of illness within DRGs: impact on prospective payment. , 1985, American journal of public health.

[32]  P. Krasilnikoff,et al.  Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. , 1984, Archives of disease in childhood.

[33]  G. M. Stokes,et al.  Ineffectiveness of ipratropium bromide in acute bronchiolitis. , 1983, Archives of disease in childhood.

[34]  J. Hyde,et al.  Corticosteroid treatment in bronchiolitis. A controlled, collaborative study in 297 infants and children. , 1969, American journal of diseases of children.